Notably, CXCL9, CXCL10, and CXCL11 utilize the shared receptor CXCR3 and engage in similar mechanisms that facilitate the recruitment of T cells and other immune cells to the tumor microenvironment, contributing to antitumor responsiveness. The gene discussed is CXCL9; the disease is neoplasm.